MedPath

Detection of Urinary Stones on ULDCT With Deep-learning Image Reconstruction Algorithm

Not Applicable
Active, not recruiting
Conditions
Renal Colic
Urinary Tract Stones
Urolithiasis
Deep Learning Reconstruction
Registration Number
NCT04490343
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Urolithiasis has an increasing incidence and prevalence worldwide, and some patients may have multiple recurrences. Because these stone-related episodes may lead to multiple diagnostic examinations requiring ionizing radiation, urolithiasis is a natural target for dose reduction efforts. Abdominopelvic low dose CT, which has the highest sensitivity and specificity among available imaging modalities, is the most appropriate diagnostic exam for this pathology. The main objective of this study is to evaluate the diagnostic performance of ultra-low dose CT using deep learning-based reconstruction in urolithiasis patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Age ≥ 18 years old,
  • Patient referred for abdominopelvic CT to confirm urolithiasis or for follow-up,
  • Affiliation to a social security program,
  • Ability of the subject to understand and express opposition
Exclusion Criteria
  • Age <18 years old,
  • Person under guardianship or curators,
  • Pregnant woman,
  • Any contraindications to CT

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Accuracy between low dose CT using DLIR reconstruction and low dose CT without DLIR reconstruction for the detection of urinary tract stonesday 1

Accuracy between low dose CT using DLIR reconstruction and low dose CT without DLIR reconstruction for the detection of urinary tract stones.

Patients who were referred to the department for abdominopelvic CT exam for urolithiasis diagnostic or follow-up, and had consented to participate in the study, will undergo an additional ultra-low dose acquisition (ULD, \<1 mSv) with deep learning-based reconstruction (DLIR).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath